Healthcare Services Group Inc. Common Stock (HCSG)
StalwartFairStock Score: 62/100 — STEADY
Key Financials
| Current Price | $21.25 |
| Market Cap | $1.5B |
| P/E Ratio | 22.37 |
| ROE | 13.21% |
| Dividend Yield | —% |
| Sector | Healthcare |
Strengths
- Solid return on equity of 13.2% above cost of capital
- Conservative balance sheet with debt-to-equity of just 0.02, providing financial flexibility
- Altman Z-Score of 5.0 confirms minimal bankruptcy risk and strong solvency
- Established organization with 36,000 employees providing operational scale
Concerns
- Trades significantly above Graham Number ($13) with negative 75% margin of safety—limited downside protection
AI Analysis
Healthcare Services Group Inc. Common Stock is a micro-cap healthcare company valued at $1.5 billion. The business generates $1.9 billion in annual revenue with a 1.4% net margin. From a quality standpoint, Healthcare shows solid Piotroski F-Score of 6/9 and Altman Z-Score of 5.0 confirms fortress-level solvency. On valuation, the stock is reasonably priced at 22.7x earnings, with trades above its Graham Number with a negative 75% margin. Growth dynamics show revenue growing at 6.6% and profit growth of 162.1%. Our composite FairStock Score of 62/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer